Chang Hee Lee

Title: Chang Hee Lee: Innovator in Cancer Detection Technologies

Introduction

Chang Hee Lee is a prominent inventor based in Tempe, AZ (US). He has made significant contributions to the field of cancer detection, particularly in renal cancer. With a total of 4 patents to his name, Lee's work is at the forefront of innovative medical technologies.

Latest Patents

One of his latest patents focuses on label-free detection of renal cancer. This innovative method involves the use of natural and/or synthetic antibodies that are adhered to nanoparticles. These nanoparticles are then attached to a substrate, which is exposed to a sample that may contain specific proteins associated with renal cancer. The substrates are subsequently tested using surface enhanced Raman scattering techniques and/or localized surface plasmon resonance techniques to quantify the amount of the specific protein in the sample. This approach represents a significant advancement in the early detection of renal cancer.

Career Highlights

Chang Hee Lee has established himself as a key figure in the research community. His work at Washington University has allowed him to explore groundbreaking technologies that have the potential to improve cancer diagnostics. His innovative methods are paving the way for more effective and less invasive detection techniques.

Collaborations

Lee has collaborated with notable colleagues in his field, including Srikanth Singamaneni and Evan David Kharasch. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Chang Hee Lee's contributions to cancer detection technologies exemplify the importance of innovation in medical research. His work not only advances scientific understanding but also holds the promise of improving patient outcomes in the fight against cancer.